SCHEMBL14347919

SCHEMBL14347919

Cc1ccc(C2(C(=O)CN3CCOCC3)CCCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ CYP2C19 P33261 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ PRCP P42785 1/20 0.47
▸ TMEM97 Q5BJF2 1/20 0.47
▸ SIGMAR1 Q99720 1/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ POLB P06746 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MAPT P10636 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14347918 0.97 MEN1 (0.48) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL14347908 0.94 MEN1 (0.50) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL8353497 0.89 USP2 (0.45) MEN1KMT2ASIGMAR1MAPK1SMN1; SMN2
SCHEMBL19242698 0.86 SMN1; SMN2 (0.62) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL8351554 0.86 USP2 (0.45) MEN1KMT2ATSHRALDH1A1SIGMAR1
SCHEMBL8351187 0.84 USP2 (0.46) MEN1KMT2ATSHRALDH1A1SIGMAR1
SCHEMBL8351183 0.83 HPGD (0.46) MEN1KMT2ATSHRALDH1A1SIGMAR1
SCHEMBL14347920 0.74 MEN1 (0.58) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL8351474 0.73 SLC6A2 (0.62) MEN1KMT2AMAPK1SMN1; SMN2POLB
SCHEMBL19242638 0.73 KMT2A (0.60) MEN1KMT2ACYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 — — US disclosed
Send feedback